{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:15:13Z","timestamp":1707524113156},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,23]]},"DOI":"10.7759\/cureus.9955","type":"journal-article","created":{"date-parts":[[2020,8,23]],"date-time":"2020-08-23T12:04:52Z","timestamp":1598184292000},"source":"Crossref","is-referenced-by-count":1,"title":["Essential Thrombocythemia in a Nonagenarian Presenting With Acute Myocardial Infarction"],"prefix":"10.7759","author":[{"given":"Junya","family":"Tanabe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madoka","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotomo","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuaki","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1816082","article-title":"Essential thrombocythemia","volume":"381","author":"Tefferi A","year":"2019","unstructured":"Tefferi A, Pardanani A. Essential thrombocythemia. N Engl J Med. 2019, 381:2135-2144. 10.1056\/NEJMcp1816082","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019004596","article-title":"A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia","volume":"136","author":"Rocca B","year":"2020","unstructured":"Rocca B, Tosetto A, Betti S, et al.. A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia. Blood. 2020, 136:171-182. 10.1182\/blood.2019004596","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-05-643346","article-title":"How I treat essential thrombocythemia","volume":"128","author":"Rumi E","year":"2016","unstructured":"Rumi E, Cazzola M. How I treat essential thrombocythemia. Blood. 2016, 128:2403-2414. 10.1182\/blood-2016-05-643346","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2018.08.022","article-title":"3023 Mayo Clinic patients with myeloproliferative neoplasms: risk-stratified comparison of survival and outcomes data among disease subgroups","volume":"94","author":"Szuber N","year":"2019","unstructured":"Szuber N, Mudireddy M, Nicolosi M, et al.. 3023 Mayo Clinic patients with myeloproliferative neoplasms: risk-stratified comparison of survival and outcomes data among disease subgroups. Mayo Clin Proc. 2019, 94:599-610. 10.1016\/j.mayocp.2018.08.022","journal-title":"Mayo Clin Proc"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2008.004234","article-title":"Significant increase in the apparent incidence of essential thrombocythemia related to new WHO diagnostic criteria: a population-based study","volume":"94","author":"Girodon F","year":"2009","unstructured":"Girodon F, Bonicelli G, Schaeffer C, et al.. Significant increase in the apparent incidence of essential thrombocythemia related to new WHO diagnostic criteria: a population-based study. Haematologica. 2009, 94:865-869. 10.3324\/haematol.2008.004234","journal-title":"Haematologica"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1532\/IJH97.06009","article-title":"Clinical features of polycythemia vera and essential thrombocythemia in Japan: retrospective analysis of a nationwide survey by the Japanese Elderly Leukemia and Lymphoma Study Group","volume":"83","author":"Dan K","year":"2006","unstructured":"Dan K, Yamada T, Kimura Y, et al.. Clinical features of polycythemia vera and essential thrombocythemia in Japan: retrospective analysis of a nationwide survey by the Japanese Elderly Leukemia and Lymphoma Study Group. Int J Hematol. 2006, 83:443-449. 10.1532\/IJH97.06009","journal-title":"Int J Hematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-012-0042-0","article-title":"Efficacy and safety of cytoreductive therapies in patients with essential thrombocythaemia aged >80 years: an Interim Analysis of the EXELS study","volume":"33","author":"Kiladjian JJ","year":"2013","unstructured":"Kiladjian JJ, Besses C, Griesshammer M, et al.. Efficacy and safety of cytoreductive therapies in patients with essential thrombocythaemia aged >80 years: an Interim Analysis of the EXELS study. Clin Drug Investig. 2013, 33:55-63. 10.1007\/s40261-012-0042-0","journal-title":"Clin Drug Investig"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/39338-essential-thrombocythemia-in-a-nonagenarian-presenting-with-acute-myocardial-infarction","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:24:54Z","timestamp":1707506694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/39338-essential-thrombocythemia-in-a-nonagenarian-presenting-with-acute-myocardial-infarction"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,23]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.9955","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8,23]]}}}